Christopher D Jaeger1, Andrew D Rule2, Ramila A Mehta3, Lisa E Vaughan3, Terri J Vrtiska4, David R Holmes5, Cynthia M McCollough3, Matthew J Ziegelmann1, Loren P Herrera Hernandez6, John C Lieske2, Amy E Krambeck7. 1. Department of Urology, Mayo Clinic School of Medicine, Rochester, MN. 2. Division of Hypertension and Nephrology, Mayo Clinic School of Medicine, Rochester, MN. 3. Division of Health Science Research, Mayo Clinic School of Medicine, Rochester, MN. 4. Department of Radiology, Mayo Clinic School of Medicine, Rochester, MN. 5. Biomedical Imaging Center, Mayo Clinic School of Medicine, Rochester, MN. 6. Department of Laboratory Medicine and Pathology, Mayo Clinic School of Medicine, Rochester, MN. 7. Department of Urology, Mayo Clinic School of Medicine, Rochester, MN. Electronic address: krambeck.amy@mayo.edu.
Abstract
OBJECTIVE: To describe the endoscopic characteristics of renal papillae in struvite stone formers (SFs). MATERIALS AND METHODS: From 2009 to 2014, patients undergoing percutaneous nephrolithotomy were prospectively enrolled in our study. Endoscopic analysis and biopsy of papillae were performed to demonstrate the presence and percentage surface area (SA) of Randall's plaque or ductal plug. Comparison with idiopathic calcium oxalate (CaOx) SF and non-SF controls was performed. RESULTS: We identified 29 struvite SFs to compare with 90 idiopathic CaOx SFs and 17 controls. On endoscopic mapping, 28 struvite SFs (97%) demonstrated Randall's plaque and 9 (31%) had plugging. The average mean SA of Randall's plaque in struvite SF (1.5 ± 1.4%) was less than CaOx SFs (3.7 ± 4.3%, P = .0018) and similar to controls (1.7 ± 2.7%, P = .76). Average mean plug SA was similar between struvite SFs, CaOx SFs, and controls. On metabolic assessment, 83% of struvite SFs had at least one urine abnormality, with urinary uric acid and oxalate levels significantly higher among struvite SFs compared to controls (P = .002). Despite lack of active urinary tract infection, interstitial inflammation was more prevalent in struvite SFs compared to CaOx SFs (43.5% vs 7.3%, P = .0001). CONCLUSIONS: Our findings suggest a limited role for Randall's plaque in struvite stone formation. Struvite SFs have less plaque formation than CaOx SFs, but demonstrate evidence of severe parenchymal inflammation compared to other SFs. The role of this prominent interstitial inflammation requires further study.
OBJECTIVE: To describe the endoscopic characteristics of renal papillae in struvite stone formers (SFs). MATERIALS AND METHODS: From 2009 to 2014, patients undergoing percutaneous nephrolithotomy were prospectively enrolled in our study. Endoscopic analysis and biopsy of papillae were performed to demonstrate the presence and percentage surface area (SA) of Randall's plaque or ductal plug. Comparison with idiopathic calcium oxalate (CaOx) SF and non-SF controls was performed. RESULTS: We identified 29 struvite SFs to compare with 90 idiopathic CaOx SFs and 17 controls. On endoscopic mapping, 28 struvite SFs (97%) demonstrated Randall's plaque and 9 (31%) had plugging. The average mean SA of Randall's plaque in struvite SF (1.5 ± 1.4%) was less than CaOx SFs (3.7 ± 4.3%, P = .0018) and similar to controls (1.7 ± 2.7%, P = .76). Average mean plug SA was similar between struvite SFs, CaOx SFs, and controls. On metabolic assessment, 83% of struvite SFs had at least one urine abnormality, with urinary uric acid and oxalate levels significantly higher among struvite SFs compared to controls (P = .002). Despite lack of active urinary tract infection, interstitial inflammation was more prevalent in struvite SFs compared to CaOx SFs (43.5% vs 7.3%, P = .0001). CONCLUSIONS: Our findings suggest a limited role for Randall's plaque in struvite stone formation. Struvite SFs have less plaque formation than CaOx SFs, but demonstrate evidence of severe parenchymal inflammation compared to other SFs. The role of this prominent interstitial inflammation requires further study.
Authors: Ramsay L Kuo; James E Lingeman; Andrew P Evan; Ryan F Paterson; Joan H Parks; Sharon B Bledsoe; Larry C Munch; Fredric L Coe Journal: Kidney Int Date: 2003-12 Impact factor: 10.612
Authors: Andrew P Evan; James E Lingeman; Fredric L Coe; Youzhi Shao; Joan H Parks; Sharon B Bledsoe; Carrie L Phillips; Stephen Bonsib; Elaine M Worcester; Andre J Sommer; Sam C Kim; William W Tinmouth; Marc Grynpas Journal: Kidney Int Date: 2005-02 Impact factor: 10.612
Authors: Michael S Borofsky; Casey A Dauw; Andrew Cohen; James C Williams; Andrew P Evan; James E Lingeman Journal: Nat Rev Urol Date: 2016-08-23 Impact factor: 14.432
Authors: Andrew P Evan; Fredric L Coe; Elaine M Worcester; James C Williams; Joshua Heiman; Sharon Bledsoe; Andre Sommer; Carrie L Philips; James E Lingeman Journal: J Endourol Date: 2020-02-03 Impact factor: 2.942